Indegene IPO lists at 46% premium on BSE and 45% on NSE

New Delhi Shares of healthcare tech firm Indegene Ltd. were listed on Monday at a premium of nearly 46 per cent against the issue price of ₹452.

New Delhi Shares of healthcare tech firm Indegene Ltd. were listed on Monday at a premium of nearly 46 per cent against the issue price of ₹452.

 The stock listed at ₹659.70, up 45.95 per cent from the issue price on the BSE.

 At the NSE, it started the trade at ₹655, registering a 44.91 per cent gain.

 The Initial Public Offer (IPO) of Indegene was subscribed 69.71 times on Wednesday, last week’s closing day of bidding.

Read: Indegene IPO subscribed 69.70 times as institutions bid aggressively The ₹1,841.75 crore IPO had a fresh issue of up to ₹760 crore and an offer-for-sale of up to 2,39,32,732 equity shares.

 The price band for the offer was ₹430-452 a share.

 Funds raised through the fresh issue would be used to pay debt, fund capital expenditure requirements, for payment of deferred consideration for one of its past acquisitions, funding inorganic growth and general corporate purposes.

 Founded in 1998, Indegene offers solutions that help enable biopharmaceutical, emerging biotech and medical devices companies to develop products, launch them in the market, and drive sales throughout their life cycle. 

Like (0)
Previous May 13, 2024 4:10 pm
Next May 13, 2024 4:10 pm

Related posts

  • Zhang Yaoxi: Gold is under pressure and fluctuating, crude oil is paying attention to mid-week rail support to maintain upward movement

    On April 25, today, Thursday, the opening of gold was affected by the efforts to stop the decline in late overnight trading, and the downward trend slowed down and stopped falling. The U.S. dollar index rebounded in early trading due to the weakening of short-term moving average pressure, which provided support for it; however, overall, There is still some room for decline in the daily chart of the U.S. dollar index. We need to pay attention to the mid-line support. The weekly chart is also expected to fall further and hit the 5-week or 10-week moving average support before rebounding again. Therefore, for the gold price, it will stop its decline in the short term. rebounded and then fell into a consolidation pattern. The 10-year U.S. bond yield has clear bullish prospects and signals in the daily, weekly and monthly charts, which will limit the bullish momentum of gold prices. Therefore, the gold price outlook will be volatile and weak. Pay attention to the range formed by the upper and lower rails of the Bollinger Bands on the daily chart….

    stock options April 25, 2024
  • Midday markets show mixed trends; Nifty, Sensex down

    NSE Nifty was down by 0.26 per cent or 57 points to 22,245, while the BSE Sensex was at 73,307 down by 0.28 per cent or 204 points. A total of 3,015 stocks were actively traded, 1,720 advanced, while 1,182 declined and 113 stocks remained unchanged where 61 stocks hit a 52 week high and 21 stocks hit a 52 week low at 9.50 am on the BSE.

    stock options May 8, 2024
  • Xianglong Electric (600769.SH): Net profit will increase by 14.00% year-on-year in 2023

    Gelonghui April 25 | Xianglong Electric (600769.SH) released its 2023 annual report. During the reporting period, the company achieved operating income of 66.5971 million yuan, a year-on-year increase of 30.15%; the net profit attributable to shareholders of the listed company was 12.1593 million yuan. , a year-on-year increase of 14.00%; net profit attributable to shareholders of listed companies after excluding non-recurring gains and losses was 11.0923 million yuan, a year-on-year increase of 56.21%; basic earnings per share was 0.0324 yuan/share.

    stock options April 25, 2024
  • Barclays: The U.S. dollar is expected to benefit from global fund managers’ end-of-month rebalancing buying

    Barclays foreign exchange strategists said the dollar is expected to be supported by strong buying interest in the end-of-month rebalancing of global fund managers\’ portfolios for the first time since November.

    stock options April 26, 2024
  • Caplin Point: What should investors do

    Caplin Point Laboratories has shown remarkable progress and continues to be on a growth path. Earlier, in July 2022, we recommended that investors accumulate the stock, and the stock, after returning 90 per cent, is still poised for further growth. At 18 times one-year forward earnings, it is at a premium to its historical valuation range of 16 times. But considering earnings growth visibility and modest valuations compared to bigger players (averaging 23 times one-year forward earnings), we reiterate the accumulate call on Caplin Point.

    stock options April 22, 2024
  • Google A fell 1.65%, OpenAI may release AI search competing products next week

    Gelonghui May 10 | Google A (GOOGL.US) fell 1.65% to $167.155

    stock options May 10, 2024